206 related articles for article (PubMed ID: 23814025)
1. PTP1B contributes to calreticulin-induced metastatic phenotypes in esophageal squamous cell carcinoma.
Wang XM; Shang L; Zhang Y; Hao JJ; Shi F; Luo W; Zhang TT; Wang BS; Yang Y; Liu ZH; Zhan QM; Wang MR
Mol Cancer Res; 2013 Sep; 11(9):986-94. PubMed ID: 23814025
[TBL] [Abstract][Full Text] [Related]
2. Calreticulin promotes migration and invasion of esophageal cancer cells by upregulating neuropilin-1 expression via STAT5A.
Shi F; Shang L; Pan BQ; Wang XM; Jiang YY; Hao JJ; Zhang Y; Cai Y; Xu X; Zhan QM; Wang MR
Clin Cancer Res; 2014 Dec; 20(23):6153-62. PubMed ID: 25231404
[TBL] [Abstract][Full Text] [Related]
3. Calreticulin promotes cell motility and enhances resistance to anoikis through STAT3-CTTN-Akt pathway in esophageal squamous cell carcinoma.
Du XL; Yang H; Liu SG; Luo ML; Hao JJ; Zhang Y; Lin DC; Xu X; Cai Y; Zhan QM; Wang MR
Oncogene; 2009 Oct; 28(42):3714-22. PubMed ID: 19684620
[TBL] [Abstract][Full Text] [Related]
4. PTP1B up-regulates EGFR expression by dephosphorylating MYH9 at Y1408 to promote cell migration and invasion in esophageal squamous cell carcinoma.
Pan BQ; Xie ZH; Hao JJ; Zhang Y; Xu X; Cai Y; Wang MR
Biochem Biophys Res Commun; 2020 Jan; 522(1):53-60. PubMed ID: 31735331
[TBL] [Abstract][Full Text] [Related]
5. BRCA1-Associated Protein Increases Invasiveness of Esophageal Squamous Cell Carcinoma.
Zhao Y; Wei L; Shao M; Huang X; Chang J; Zheng J; Chu J; Cui Q; Peng L; Luo Y; Tan W; Tan W; Lin D; Wu C
Gastroenterology; 2017 Nov; 153(5):1304-1319.e5. PubMed ID: 28780075
[TBL] [Abstract][Full Text] [Related]
6. Downregulation of MiR-31 stimulates expression of LATS2 via the hippo pathway and promotes epithelial-mesenchymal transition in esophageal squamous cell carcinoma.
Gao Y; Yi J; Zhang K; Bai F; Feng B; Wang R; Chu X; Chen L; Song H
J Exp Clin Cancer Res; 2017 Nov; 36(1):161. PubMed ID: 29145896
[TBL] [Abstract][Full Text] [Related]
7. ING5 inhibits cell proliferation and invasion in esophageal squamous cell carcinoma through regulation of the Akt/NF-κB/MMP-9 signaling pathway.
Zhang GJ; Zhao J; Jiang ML; Zhang LC
Biochem Biophys Res Commun; 2018 Feb; 496(2):387-393. PubMed ID: 29326045
[TBL] [Abstract][Full Text] [Related]
8. Up-regulation of long noncoding RNA MALAT1 contributes to proliferation and metastasis in esophageal squamous cell carcinoma.
Hu L; Wu Y; Tan D; Meng H; Wang K; Bai Y; Yang K
J Exp Clin Cancer Res; 2015 Jan; 34(1):7. PubMed ID: 25613496
[TBL] [Abstract][Full Text] [Related]
9. MiR-99a suppresses proliferation, migration and invasion of esophageal squamous cell carcinoma cells through inhibiting the IGF1R signaling pathway.
Mei LL; Qiu YT; Huang MB; Wang WJ; Bai J; Shi ZZ
Cancer Biomark; 2017 Dec; 20(4):527-537. PubMed ID: 28800315
[TBL] [Abstract][Full Text] [Related]
10. Low SOX17 expression is a prognostic factor and drives transcriptional dysregulation and esophageal cancer progression.
Kuo IY; Wu CC; Chang JM; Huang YL; Lin CH; Yan JJ; Sheu BS; Lu PJ; Chang WL; Lai WW; Wang YC
Int J Cancer; 2014 Aug; 135(3):563-73. PubMed ID: 24407731
[TBL] [Abstract][Full Text] [Related]
11. MiR-130b plays an oncogenic role by repressing PTEN expression in esophageal squamous cell carcinoma cells.
Yu T; Cao R; Li S; Fu M; Ren L; Chen W; Zhu H; Zhan Q; Shi R
BMC Cancer; 2015 Jan; 15():29. PubMed ID: 25637514
[TBL] [Abstract][Full Text] [Related]
12. Catalytically defective receptor protein tyrosine kinase PTK7 enhances invasive phenotype by inducing MMP-9 through activation of AP-1 and NF-κB in esophageal squamous cell carcinoma cells.
Shin WS; Hong Y; Lee HW; Lee ST
Oncotarget; 2016 Nov; 7(45):73242-73256. PubMed ID: 27689325
[TBL] [Abstract][Full Text] [Related]
13. Identification of PTK6, via RNA sequencing analysis, as a suppressor of esophageal squamous cell carcinoma.
Ma S; Bao JYJ; Kwan PS; Chan YP; Tong CM; Fu L; Zhang N; Tong AHY; Qin YR; Tsao SW; Chan KW; Lok S; Guan XY
Gastroenterology; 2012 Sep; 143(3):675-686.e12. PubMed ID: 22705009
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic silencing of HIC1 promotes epithelial-mesenchymal transition and drives progression in esophageal squamous cell carcinoma.
Li P; Liu X; Dong ZM; Ling ZQ
Oncotarget; 2015 Nov; 6(35):38151-65. PubMed ID: 26510908
[TBL] [Abstract][Full Text] [Related]
15. High expression of Collagen Triple Helix Repeat Containing 1 (CTHRC1) facilitates progression of oesophageal squamous cell carcinoma through MAPK/MEK/ERK/FRA-1 activation.
Wang C; Li Z; Shao F; Yang X; Feng X; Shi S; Gao Y; He J
J Exp Clin Cancer Res; 2017 Jun; 36(1):84. PubMed ID: 28645305
[TBL] [Abstract][Full Text] [Related]
16. Loss of Protein Tyrosine Phosphatase Receptor J Expression Predicts an Aggressive Clinical Course in Patients with Esophageal Squamous Cell Carcinoma.
Qiao D; Li M; Pu J; Wang W; Zhu W; Liu H
Pathol Oncol Res; 2016 Jul; 22(3):541-7. PubMed ID: 26694178
[TBL] [Abstract][Full Text] [Related]
17. SOX2 Promotes the Epithelial to Mesenchymal Transition of Esophageal Squamous Cells by Modulating Slug Expression through the Activation of STAT3/HIF-α Signaling.
Gao H; Teng C; Huang W; Peng J; Wang C
Int J Mol Sci; 2015 Sep; 16(9):21643-57. PubMed ID: 26370982
[TBL] [Abstract][Full Text] [Related]
18. Increased expression of EIF5A2, via hypoxia or gene amplification, contributes to metastasis and angiogenesis of esophageal squamous cell carcinoma.
Li Y; Fu L; Li JB; Qin Y; Zeng TT; Zhou J; Zeng ZL; Chen J; Cao TT; Ban X; Qian C; Cai Z; Xie D; Huang P; Guan XY
Gastroenterology; 2014 Jun; 146(7):1701-13.e9. PubMed ID: 24561231
[TBL] [Abstract][Full Text] [Related]
19. RNF113A promotes the proliferation, migration and invasion, and is associated with a poor prognosis of esophageal squamous cell carcinoma.
Wang L; Hou Z; Hasim A; Abuduerheman A; Zhang H; Niyaz M; Awut I; Upur H; Sheyhidin I
Int J Oncol; 2018 Mar; 52(3):861-871. PubMed ID: 29393393
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of SALL4 reduces tumorigenicity involving epithelial-mesenchymal transition via Wnt/β-catenin pathway in esophageal squamous cell carcinoma.
He J; Zhou M; Chen X; Yue D; Yang L; Qin G; Zhang Z; Gao Q; Wang D; Zhang C; Huang L; Wang L; Zhang B; Yu J; Zhang Y
J Exp Clin Cancer Res; 2016 Jun; 35(1):98. PubMed ID: 27329034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]